Marker Therapeutics, Inc. (MRKR)

2.00 -0.07 (-3.38%) USD  |  NASDAQ  |  Jan 09, 16:00
2.05 +0.05 (+2.50%) Pre-Market: 20:00
More

Marker Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
AIM ImmunoTech, Inc. Upgrade